Item 8.01 Other Events.
On January 28, 2020, OpGen, Inc. (the "Company") issued a press release
announcing a special meeting date of March 10, 2020, for its stockholders to,
among other things, consider and vote on a proposal to adopt the previously
announced business combination with Curetis GmbH ("Curetis"). A copy of the
press release is attached hereto as Exhibit 99.1 and is incorporated herein by
reference.
On January 30, 2020, the Company issued a press release providing an update on
the business of Curetis, a copy of which is attached as Exhibit 99.2 to this
Current Report and is incorporated herein by reference.
No Offer or Solicitation
These press releases filed herewith are neither offers to purchase, nor
solicitations of an offer to sell, any securities or the solicitation of any
vote in any jurisdiction pursuant to the proposed transactions or otherwise, nor
shall there be any sale, issuance or transfer or securities in any jurisdiction
in contravention of applicable law. No offer of securities shall be made except
by means of a prospectus meeting the requirements of Section 10 of the
Securities Act of 1933, as amended.
Additional Information and Where to Find It
In connection with the transactions contemplated by the Implementation Agreement
(the definitive agreement related to the proposed business combination between
the Company and Curetis), a Registration Statement on Form S-4 (File No.
333-234657) has been filed with and declared effective by the Securities and
Exchange Commission (the "SEC"). Investors and security holders are encouraged
to read the registration statement and any other relevant documents filed with
the SEC, including the proxy statement/prospectus that forms a part of the
registration statement. Such documents contain important information about the
proposed transaction. The definitive proxy statement/prospectus was first mailed
to stockholders of the Company on or about January 27, 2020. This communication
is not a substitute for the registration statement, the proxy
statement/prospectus or any other document that the Company may send to its
stockholders in connection with the proposed transaction. Investors and security
holders will be able to obtain the documents free of charge at the SEC's
website, www.sec.gov, or from the Company at its website, www.opgen.com.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits
Exhibit No. Document
99.1 Press Release issued by OpGen, Inc. dated January 28, 2020
99.2 Press Release issued by OpGen, Inc. dated January 30, 2020
© Edgar Online, source Glimpses